Canada markets open in 5 hours 44 minutes

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1400-0.0050 (-3.45%)
At close: 03:26PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.77M
Enterprise Value 5.18M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)29.50
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.03

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-57.35%
S&P500 52-Week Change 3-13.12%
52 Week High 30.3500
52 Week Low 30.0750
50-Day Moving Average 30.1205
200-Day Moving Average 30.1176

Share Statistics

Avg Vol (3 month) 315.95k
Avg Vol (10 day) 321.38k
Shares Outstanding 539.79M
Implied Shares Outstanding 6N/A
Float 831.96M
% Held by Insiders 130.86%
% Held by Institutions 10.00%
Shares Short (Oct 13, 2022) 45k
Short Ratio (Oct 13, 2022) 40.57
Short % of Float (Oct 13, 2022) 4N/A
Short % of Shares Outstanding (Oct 13, 2022) 40.01%
Shares Short (prior month Jun 14, 2022) 4621

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2022
Most Recent Quarter (mrq)Jul 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-92.62%
Return on Equity (ttm)-200.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.51M
Net Income Avi to Common (ttm)-2.55M
Diluted EPS (ttm)-0.1480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)593.21k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.27
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-2.19M
Levered Free Cash Flow (ttm)-1.21M